BioSign Rapid Flu A+B Test

• Sold in: Box of 25 Tests
• CLIA Waived & FDA Approved

Reimbursement Information

An In vitro rapid qualitative test that detects influenza type A and type B antigens directly from nasal swab, nasopharyngeal swab and nasal aspirate/wash specimens.

Features:

• Differentiates between Influenza Type A and B, on a single test device
• Produces results in 10 to 15 minutes
• Each test device includes built-in controls
• Each kit comes with external controls
• Meets FDA performance criteria for influenza tests stated in code 21 CFR 866.3328
• CLIA Complexity: Moderate complexity when used with nasal wash/aspirate samples
• CLIA Waived when used with nasal and nasopharyngeal swabs

SKU: BSP510-25